1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Modified FOLFOX6: new trials by email Literature Review of Modified FOLFOX6 trials Research Report on Modified FOLFOX6
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC NIS793, Bevacizumab, Modified FOLFOX6 - Metastatic Colorectal Cancer | Phase 2 | Terminated | Novartis Pharmaceuticals | 204 | 2021-11-15 | 2025-03-26 |
Australia (1) · Belgium (1) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Hong Kong (1) · Israel (1) · Italy (1) · Japan (1) · Singapore (1) · South Korea (1) · Spain (1) · Switzerland (1) · Taiwan (1)